Case Report: A 29-Year-Old Pregnant Woman at 24 Weeks of Gestation Presenting with Laryngotracheitis and COVID-19 Due to the R.1 Variant of SARS-CoV-2Article Published on 2022-10-182022-11-16 Journal: The American journal of case reports [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome Admission Adults adverse effect causes coronavirus Corticosteroid Corticosteroids cough COVID-19 discharge discharged disease E484K mutation edema Fever gestation healthy hospital Hospitalized Inhaled laryngotracheitis Lower respiratory tract nebulized oxygen saturation PCR polymerase chain positive Pregnancy Pregnant woman pregnant women presenting primary care SARS-CoV-2 severe disease course sore throat Symptom Symptoms treated Treatment variant of SARS-CoV-2 Week with COVID-19 woman Wuhan, China [DOI] 10.12659/AJCR.937834 PMC 바로가기
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccinationArticle Published on 2022-10-042022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] administration Adverse adverse effect anti-RBD Anti-RBD IgG antibody Antibody Response Arm ARMS binding domain BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 comparable Concentration conducted CoronaVac country COVID COVID vaccine COVID-19 COVID-19 vaccine COVID-19 vaccines dose Effect Effects eligible exploratory first dose fractional dose vaccination Frame Heterologous heterologous regimen highest homologous IgG immunogenic implication IMPROVE Intradermal intradermal vaccination intradermal vaccine intramuscular intramuscular vaccination less lowest of BNT162b2 Omicron variant pilot study Population Protein regimen regimens reported Safe Safety SARS-CoV-2 variants second dose spike Standard dose Study participants systemic adverse reaction T-cell Response the SARS-CoV-2 undetectable vaccination Vaccine vaccine immunogenicity vaccine safety [DOI] 10.3389/fimmu.2022.1010835 PMC 바로가기
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risksReview Published on 2022-10-012023-07-10 Journal: Expert review of vaccines [Category] COVID19(2023년), [키워드] adverse effect coronavirus-disease 2019 (COVID-19) severe acute respiratory coronavirus 2 (SARS-CoV-2). Vaccine [DOI] 10.1080/14760584.2022.2116008 [Article Type] Review
Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune responseArticle Published on 2022-10-012022-11-15 Journal: Journal of internal medicine [Category] 진단, [키워드] acute respiratory syndrome Adults adverse effect adverse event adverse events Ageusia angiotensin-converting enzyme 2 Anosmia Bacillus BCG center clinical clinical evolution clinical trial convalescence convalescent coronavirus coronavirus disease COVID-19 cross-protection double-blind evaluated Evolution expected Follow-up humoral humoral immune response IgG Immunoglobulin immunomodulation induce lesions Local modulation multicenter N protein neutralization neutralize NNT offer Other outcome Outpatient Patient Placebo placebo-controlled placebos prevented Primary outcome proportion Randomized receptor recipient Safe Safety SARS-CoV-2 serum Seven severely ill patient significantly higher South America statistically significant systemic adverse effects treat university Vaccine viral disease virus [DOI] 10.1111/joim.13523 PMC 바로가기
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysisArticle Published on 2022-10-012022-11-15 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 진단, [키워드] adjusted adverse effect age Analysis Anti-spike binding antibody unit binding domain boost Combination Complete Concentration COVID COVID-19 doses enrolled evaluated event female Frequency Gam-COVID-Vac Gender Heterologous Heterologous scheme homologous humoral humoral immune response IgG immunization increase individual induce interquartile range IQR Linear model median Mild moderate Moderna mRNA-1273 participant RBD real-world data required SARS-CoV-2 Serological assay Seven significantly significantly higher vaccination Vaccine [DOI] 10.1016/j.cmi.2022.05.009 PMC 바로가기
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationArticle Published on 2022-10-012022-11-15 Journal: Annals of neurology [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI 95% confidence interval adenovirus-based adjusted adjusted odds ratio administration adverse effect analyzed ANN Anticoagulant Anticoagulants association autoimmune pathogenesis avoidance caused cerebral country COVID-19 diagnosed evaluate had no heparin hospital immune immunomodulation International Intravenous immunoglobulin lower mortality Mortality Patient Platelet recommendation reducing mortality SARS-CoV-2 SARS-CoV-2 vaccination significantly statistically significant the patient thrombotic treated Treatment used data Vaccines Venous thrombosis [DOI] 10.1002/ana.26431 PMC 바로가기
Interactions of the protease inhibitor, ritonavir, with common anesthesia drugsArticle Published on 2022-10-012022-11-15 Journal: Paediatric anaesthesia [Category] 치료제, [키워드] administration adverse effect affected Altered Anesthesia Antiviral antiviral drug approach Bioavailability change changes in children clearance Combination Comorbidities Concentration COVID-19 dependent on drug drug clearance drug dose Drug interactions early treatment enzyme example fentanyl increase in inhibited inhibitor inhibitory intrinsic management metabolic pathways pathway Patient Pharmacodynamics pharmacokinetic plasma concentration propofol Protease inhibitor remifentanil responsible Ritonavir subject Variability [DOI] 10.1111/pan.14529 PMC 바로가기
Constrictive pericarditis following inactivated virus COVID-19 vaccine: a case report with review of the literatureCase report Published on 2022-10-012022-10-05 Journal: Radiology Case Reports [Category] 진단, [키워드] accelerate adverse effect BBIBP-CorV (Vero Cells) cardiac Case report catheterization chest CT scan Constrictive pericarditis corticosteroid therapy Course COVID-19 COVID-19 vaccine Diagnosis diagnostic diagnostic investigation diagnostic test dose etiology exclusion favor heart failure immunization inactivated Inactivated vaccine Inflammation invasive lack male mRNA COVID-19 vaccines myocarditis Patient physician provoke receiving reported SARS-CoV-2 Symptom the patient virus was performed [DOI] 10.1016/j.radcr.2022.07.021 [Article Type] Case report
Impact of COVID-19 on male urogenital health: Success of vaccinesReview article Published on 2022-10-012022-10-05 Journal: Drug discovery today [Category] COVID19(2023년), SARS, 신약개발, 임상, [키워드] acute respiratory syndrome adverse effect angiotensin-converting enzyme 2 approval Community consequence coronavirus COVID-19 COVID-19 pandemic COVID-19 vaccinations Erectile dysfunction Impact information male management morbidity and mortality Prostate SARS-CoV-2 treatment protocols Urinary bladder Vaccine [DOI] 10.1016/j.drudis.2022.07.012 [Article Type] Review article
Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cellsArticle Published on 2022-09-162022-11-15 Journal: Scientific Reports [Category] SARS, 진단, [키워드] ACE2-positive cell addition ADE ADE activity adverse effect anti-SARS-CoV-2 antibody Antibody-dependent enhancement Antisera approved caused collected concentrations COVID-19 pandemic examined exhibited FcR in vivo individual Infection inoculated mAb mAbs monoclonal mRNA vaccines Neutralizing Neutralizing activity omicron S-protein SARS-CoV-2 spike protein sera therapeutic therapeutic effect [DOI] 10.1038/s41598-022-19993-w PMC 바로가기